Sagar Drugs And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.10 M
as on 16-11-2024
- Paid Up Capital ₹ 1.90 M
as on 16-11-2024
- Company Age 39 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 46.93 Cr
as on 16-11-2024
- Satisfied Charges ₹ 24.60 Cr
as on 16-11-2024
- Revenue -61.06%
(FY 2023)
- Profit -309.53%
(FY 2023)
- Ebitda -767.60%
(FY 2023)
- Net Worth -44.62%
(FY 2023)
- Total Assets -27.68%
(FY 2023)
About Sagar Drugs And Pharmaceuticals
The Corporate was formerly known as Sagar Drugs And Pharmaceuticals Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.10 M and a paid-up capital of Rs 1.90 M.
The company currently has active open charges totaling ₹46.93 Cr. The company has closed loans amounting to ₹24.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankur Patel, Meenaben Patel, Sagar Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24231GJ1985PTC007679
- Company No.
007679
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sagar Drugs And Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rohitbhai Patel  | Managing Director | 01-Oct-1998 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ankur Patel | Whole-Time Director | 29-Sep-1999 | Current |
| Meenaben Patel | Director | 20-Feb-2004 | Current |
| Sagar Patel | Director | 03-Mar-2003 | Current |
Financial Performance of Sagar Drugs And Pharmaceuticals.
Sagar Drugs And Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 61.06% decrease. The company also saw a substantial fall in profitability, with a 309.53% decrease in profit. The company's net worth observed a substantial decline by a decrease of 44.62%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sagar Drugs And Pharmaceuticals?
In 2023, Sagar Drugs And Pharmaceuticals had a promoter holding of 100.00%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Gpsar Healthcare LimitedActive 25 years 9 monthsAnkur Patel, Sagar Patel and 1 more are mutual person
Sar Organizers Private LimitedActive 32 years 11 monthsAnkur Patel and Rohitbhai Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 01 Jan 2022 | ₹3.20 M | Open |
Bank Of India Creation Date: 10 Dec 2013 | ₹23.30 Cr | Open |
Bank Of India Creation Date: 04 May 2012 | ₹23.30 Cr | Open |
How Many Employees Work at Sagar Drugs And Pharmaceuticals?
Sagar Drugs And Pharmaceuticals has a workforce of 37 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sagar Drugs And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sagar Drugs And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
